Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Samantha Holden

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-NEUR General Operations
Phone720/848-2080

    Collapse Biography 
    Collapse education and training
    New York University, New York, NYBS05/2006Neural Science
    Stony Brook University School of Medicine, Stony Brook, NYMD05/2010Medicine
    University of Colorado, Aurora, COMS05/2018Clinical Science
    Rush University Medical Center, Chicago, IL06/2011Internal Medicine Internship
    Rush University Medical Center, Chicago, IL06/2014Neurology Residency
    University of Colorado, Aurora, CO06/2015Movement Disorders Fellowship
    University of Colorado, Aurora, CO06/2017Behavioral Neurology Fellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison. Parkinsonism Relat Disord. 2019 Jun 23. PMID: 31253494.
      View in: PubMed
    2. Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. 2019 Mar 13; 11(1):23. PMID: 30867052.
      View in: PubMed
    3. Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease. Mov Disord. 2018 11; 33(11):1760-1768. PMID: 30306618.
      View in: PubMed
    4. Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Mov Disord. 2018 04; 33(4):503-510. PMID: 29488270.
      View in: PubMed
    5. Kluger BM, Persenaire MJ, Holden SK, Palmer LT, Redwine H, Berk J, Anderson CA, Filley CM, Kutner J, Miyasaki J, Carter J. Implementation issues relevant to outpatient neurology palliative care. Ann Palliat Med. 2018 Jul; 7(3):339-348. PMID: 29307208.
      View in: PubMed
    6. Holden SK, Finseth T, Sillau SH, Berman BD. Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort. Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):47-53. PMID: 29662921.
      View in: PubMed
    7. Holden SK, Hall DA . Non-Parkinsonian Movement Disorders. Ataxia. 2017; 68-79.
    8. Holden S, Goldman JG . Encyclopedia of Mental Health. Parkinson's Disease. 2016.
    9. Holden SK, Jones WE, Baker KA, Boersma IM, Kluger BM. Outcome measures for Parkinson's disease dementia: a systematic review. Mov Disord Clin Pract. 2016 Jan-Feb; 3(1):9-18. PMID: 26998505.
      View in: PubMed
    10. Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov Disord. 2015 Mar; 30(3):402-6. PMID: 25449653.
      View in: PubMed
    11. Goldman JG, Holden S. Treatment of psychosis and dementia in Parkinson's disease. Curr Treat Options Neurol. 2014 Mar; 16(3):281. PMID: 24464490.
      View in: PubMed
    12. Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord. 2013 Dec; 28(14):1972-9. PMID: 24123267.
      View in: PubMed
    13. Holden SK, Finseth T, Sillau SH, Berman BD. Progression of MDS-UPDRS scores over five years in de novo Parkinson disease from the PPMI cohort. Movement Disorders Clinical Practice.
    14. Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. Movement Disorders. Evolution of diagnostic criteria and assessments for Parkinson’s Disease-Mild Cognitive Impairment.
    Holden's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (28) concept(s)
    _
    Co-Authors Expand Description
    See all (9) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)